The School of Psychology proudly presents:
The Psychonomic Seminar Series 2007
"Beyond the superficial pleasures of cosy ignorance lies the unforgiving ecstasy of science"
This Friday, at 3pm in room 304, the outrageously talented Katharine Vearncombe will talk about: "The cognitive effects of chemotherapy and chemical menopause in women with early breast cancer"
Breast cancer treatment, particularly adjuvant chemotherapy, has been increasingly linked to cognitive dysfunction. Studies to date have found that a subset of women experience cognitive changes, ranging from specific deficits in verbal memory to more global deficits, both prior to and post chemotherapy treatment. However, previous research in this area contains significant methodological limitations, including small sample sizes, cross-sectional designs and use of inappropriate measures. In addition, other factors that could potentially be important to cognition have been overlooked, including chemotherapy-induced menopause (or chemical menopause) and the use of endocrine treatments. The current research aims to address these limitations through investigating the effects of chemotherapy and chemical menopause on cognitive functioning using a prospective, longitudinal design.
Selected extract from Katharines best-selling autobiography, "Me and my life: An insiders perspective" (5th edition; illustrated):
I graduated from the Bachelor of Psychological Science here at UQ in 2003, after completing an honours thesis under Ken McFarland on the effects of a simulated fMRI environment on the verbal/ manual dual task procedure. In 2004, I commenced the Doctor of Psychology program and began research in a completely different area, this time investigating the cognitive effects of endocrine treatment for early breast cancer. After a difficult year filled with recruitment woes and the loss of my first supervisor, I changed research